Rivastigmine tartrate with EDMF CTD

We are pleased to inform you that our Indian manufacturing partner CIPLA Ltd. has finalized the European Drug Master File in CTD-format for API RIVASTIGMINE TARTRATE (Antialzheimer).

If you need any further explanations, price indications, analytical samples etc. please let us know - we will try to help you in any case. The applicant's part of the EDMF CTD can be handed out against Secrecy Agreement.

Looking forward to hearing from you.

Your F. & A. PHARMA team

Back to News